Dr Simona Soverini discusses early molecular response, next-generation sequencing, and the impact of tyrosine kinase inhibitor-resistant mutations in various leukaemias.
NGS in PH+ LEUKEMIA: WATCH AN INTERVIEW WITH DR SOVERINI
2 Aug 2018
Hematology
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.